Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug

Figure 3

In vitro drug release. In vitro drug release of HANP/HCPT in an acetate buffer (Ph = 4.3, 37°C) with or without hyaluronidase (Hyal). The HCPT quickly released from HANP/HCPT complex in the presence of Hyal, which can degrade HANP. denotes .